Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Standard Biotools (LAB) Long-Term Debt Issuances (2021 - 2022)

Standard Biotools (LAB) has disclosed Long-Term Debt Issuances for 3 consecutive years, with $25.0 million as the latest value for Q1 2022.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to $25.0 million in Q1 2022 year-over-year; TTM through Dec 2022 was $25.0 million, a N/A change, with the full-year FY2022 number at $25.0 million, changed N/A from a year prior.
  • Long-Term Debt Issuances was $25.0 million for Q1 2022 at Standard Biotools, up from $1000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $25.0 million in Q1 2022 to a low of $25.0 million in Q1 2022.